60 Degrees Pharmaceuticals (SXTPW) Short term Debt (2022 - 2025)
Historic Short term Debt for 60 Degrees Pharmaceuticals (SXTPW) over the last 4 years, with Q3 2025 value amounting to $797275.0.
- 60 Degrees Pharmaceuticals' Short term Debt rose 2781.72% to $797275.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $797275.0, marking a year-over-year increase of 2781.72%. This contributed to the annual value of $640830.0 for FY2024, which is 7221.99% down from last year.
- 60 Degrees Pharmaceuticals' Short term Debt amounted to $797275.0 in Q3 2025, which was up 2781.72% from $776172.0 recorded in Q2 2025.
- In the past 5 years, 60 Degrees Pharmaceuticals' Short term Debt ranged from a high of $23.5 million in Q2 2023 and a low of $565949.0 during Q1 2024
- In the last 4 years, 60 Degrees Pharmaceuticals' Short term Debt had a median value of $776172.0 in 2025 and averaged $3.1 million.
- In the last 5 years, 60 Degrees Pharmaceuticals' Short term Debt surged by 5438.33% in 2023 and then plummeted by 9759.11% in 2024.
- Quarter analysis of 4 years shows 60 Degrees Pharmaceuticals' Short term Debt stood at $1.5 million in 2022, then surged by 54.38% to $2.3 million in 2023, then plummeted by 72.22% to $640830.0 in 2024, then grew by 24.41% to $797275.0 in 2025.
- Its Short term Debt was $797275.0 in Q3 2025, compared to $776172.0 in Q2 2025 and $635725.0 in Q1 2025.